id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-E-0226-0005,FDA,FDA-2007-E-0226,Determination of Regulatory Review Period for Purposes of Patent Extension: Brovana,Notice,General Notice,2011-06-23T04:00:00Z,2011,6,2011-06-23T04:00:00Z,2011-08-23T03:59:59Z,2025-12-15T21:00:45Z,2011-15691,0,0,0900006480e9c0d9
FDA-2007-E-0226-0004,FDA,FDA-2007-E-0226,FDA/CDER to United States Patent and Trademark Office - Letter,Other,LET-Letter,2011-05-31T04:00:00Z,2011,5,2011-05-31T04:00:00Z,,2011-05-31T17:18:05Z,,0,0,0900006480e34fa0